Luc Sauriol

521 total citations
24 papers, 355 citations indexed

About

Luc Sauriol is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Luc Sauriol has authored 24 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Economics and Econometrics and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Luc Sauriol's work include Diabetes Management and Research (13 papers), Diabetes Treatment and Management (11 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Luc Sauriol is often cited by papers focused on Diabetes Management and Research (13 papers), Diabetes Treatment and Management (11 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Luc Sauriol collaborates with scholars based in Canada, France and United States. Luc Sauriol's co-authors include Daniel Grima, Jean‐François Yale, Stewart B. Harris, Brett Hauber, F. Reed Johnson, Bénédicte Lescrauwaet, Hertzel C. Gerstein, Robyn L. Houlden, Stuart A. Ross and A.P. Contandriopoulos and has published in prestigious journals such as Diabetes Care, Diabetes and BMJ Open.

In The Last Decade

Luc Sauriol

21 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luc Sauriol Canada 10 189 64 54 37 37 24 355
G Goodall United States 12 176 0.9× 45 0.7× 60 1.1× 31 0.8× 18 0.5× 19 367
Angela Bowen United States 7 148 0.8× 38 0.6× 15 0.3× 23 0.6× 39 1.1× 10 374
Marco Scardapane Italy 12 207 1.1× 10 0.2× 40 0.7× 63 1.7× 26 0.7× 22 412
Gerardo Corigliano Italy 9 204 1.1× 19 0.3× 51 0.9× 67 1.8× 42 1.1× 18 427
Tibor Hídvégi Hungary 10 153 0.8× 12 0.2× 42 0.8× 19 0.5× 27 0.7× 30 368
Jean François Yale Canada 7 223 1.2× 7 0.1× 57 1.1× 47 1.3× 27 0.7× 8 375
Lindy D. Wood United States 8 118 0.6× 16 0.3× 24 0.4× 65 1.8× 6 0.2× 10 387
Laura Cohen United States 11 79 0.4× 34 0.5× 165 3.1× 39 1.1× 6 0.2× 33 448
León Litwak Argentina 13 465 2.5× 16 0.3× 33 0.6× 108 2.9× 55 1.5× 37 642
Priya Manjoo Canada 8 117 0.6× 20 0.3× 22 0.4× 43 1.2× 6 0.2× 12 223

Countries citing papers authored by Luc Sauriol

Since Specialization
Citations

This map shows the geographic impact of Luc Sauriol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Sauriol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Sauriol more than expected).

Fields of papers citing papers by Luc Sauriol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Sauriol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Sauriol. The network helps show where Luc Sauriol may publish in the future.

Co-authorship network of co-authors of Luc Sauriol

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Sauriol. A scholar is included among the top collaborators of Luc Sauriol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Sauriol. Luc Sauriol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Sauriol, Luc, et al.. (2018). Persistence with Insulin Glargine 300 IU/ml Compared with Other Basal Insulins—A Canadian Retrospective Cohort Study. Diabetes. 67(Supplement_1). 3 indexed citations
4.
Hamarneh, Yazid N. Al, et al.. (2016). Economic analysis of insulin initiation by pharmacists in a Canadian setting. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 149(3). 130–137. 4 indexed citations
5.
Hamarneh, Yazid N. Al, Luc Sauriol, & Ross T. Tsuyuki. (2015). After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study. BMJ Open. 5(8). e008152–e008152. 6 indexed citations
6.
Brown, Stephen T., et al.. (2014). Cost-effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-naïve Patients With Type 2 Diabetes Mellitus. Clinical Therapeutics. 36(11). 1576–1587. 14 indexed citations
7.
Berg, Jenny, Luc Sauriol, Stuart J. Connolly, & Peter Lindgren. (2013). Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial. Canadian Journal of Cardiology. 29(10). 1249–1255. 3 indexed citations
8.
O’Reilly, Daria, Robert Hopkins, Jeff S. Healey, et al.. (2012). The Burden of Atrial Fibrillation on the Hospital Sector in Canada. Canadian Journal of Cardiology. 29(2). 229–235. 38 indexed citations
9.
Guertin, Jason R., Marc Dorais, Paul Khairy, et al.. (2011). Atrial Fibrillation: A Real-Life Observational Study in the Québec Population. Canadian Journal of Cardiology. 27(6). 794–799. 5 indexed citations
10.
Tunis, Sandra L., Luc Sauriol, & Michael E. Minshall. (2010). Cost Effectiveness of Insulin Glargine plus Oral Antidiabetes Drugs Compared with Premixed Insulin Alone in Patients with Type 2 Diabetes Mellitus in Canada. Applied Health Economics and Health Policy. 8(4). 267–280. 16 indexed citations
11.
12.
Houlden, Robyn L., Stuart A. Ross, Stewart B. Harris, et al.. (2007). Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study. Diabetes Research and Clinical Practice. 78(2). 254–258. 55 indexed citations
13.
Grima, Daniel, et al.. (2007). Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada. PharmacoEconomics. 25(3). 253–266. 41 indexed citations
14.
Harris, Stewart B., Lawrence A. Leiter, Jean‐François Yale, et al.. (2007). Out-of-pocket Costs of Managing Hyperglycemia and Hypoglycemia in Patients With Type 1 Diabetes and Insulin-treated Type 2 Diabetes. Canadian Journal of Diabetes. 31(1). 25–33. 23 indexed citations
15.
Hauber, Brett, F. Reed Johnson, Luc Sauriol, & Bénédicte Lescrauwaet. (2005). Risking Health to Avoid Injections. Diabetes Care. 28(9). 2243–2245. 43 indexed citations
16.
Sauriol, Luc, et al.. (2001). Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach. Clinical Therapeutics. 23(6). 942–956. 21 indexed citations
17.
Sauriol, Luc, et al.. (2000). The Effect of Seasonal Allergic Rhinitis in Children on Caregivers' Lives: A Pilot Study. Pediatric Asthma Allergy & Immunology. 14(2). 119–124.
18.
Sauriol, Luc, et al.. (1999). PCN1: DIRECT AND INDIRECT TREATMENT COMPARISONS OF SECOND-GENERATION ANTIPSYCHOTIC DRUGS. Value in Health. 2(5). 384–384. 2 indexed citations
19.
Sauriol, Luc, et al.. (1998). Alzheimer's disease: a review of the disease, its epidemiology and economic impact. Archives of Gerontology and Geriatrics. 27(3). 189–221. 45 indexed citations
20.
Sauriol, Luc, et al.. (1998). Meta-analysis and economic evaluation of LH-RH agonists' depot formulations in advanced prostatic carcinoma.. PubMed. 5(3). 585–594. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Goodall Breakdown of academic impact, for papers by Angela Bowen Breakdown of academic impact, for papers by Marco Scardapane Breakdown of academic impact, for papers by Gerardo Corigliano Breakdown of academic impact, for papers by Tibor Hídvégi Breakdown of academic impact, for papers by Jean François Yale Breakdown of academic impact, for papers by Lindy D. Wood Breakdown of academic impact, for papers by Laura Cohen Breakdown of academic impact, for papers by León Litwak Breakdown of academic impact, for papers by Priya Manjoo
Rankless by CCL
2026